April 2015 | OncologyLive

New Era for Monoclonal Antibodies on Horizon in Multiple Myeloma

April 12, 2015

The prospects for mAbs to change the treatment paradigm for multiple myeloma have grown considerably brighter as early-phase clinical trial results suggest that emerging agents with novel mechanisms of action are capable of delivering significant efficacy.

Immunotherapy Innovator Jedd Wolchok Honored

April 11, 2015

Jedd D. Wolchok, MD, PhD, played an important role in the development of ipilimumab, the first drug to target an immune checkpoint as an anticancer strategy. He was honored in the Melanoma category with a 2014 Giants of Cancer Care® award.

Crossing Tumor Types: BRCA Experience Points Way to New Diagnostic Paradigm

April 01, 2015

Patients with advanced cancers of the pancreas or prostate, or where progression to this state occurs later in the course of the illness, should have tumor or germline testing performed looking for the presence of a BRCA mutation.